Author details

Full Name

Tjebo F C Heeren

Affiliation

Moorfields Eye Hospital, NHS Foundation Trust

ORCID

Career Start Year

2011

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
35301216	Intraretinal pigmented cells in retinal degenerative disease.	Br J Ophthalmol	2023
37483313	A Novel Role for Corneal Pachymetry in Planning Cataract Surgery by Determining Changes in Spherical Equivalent Resulting from a Previous LASIK Treatment.	J Ophthalmol	2023
35106403	State of the art spatial visualization of the response of neovascularisation to anti-vascular endothelial growth factor therapy.	Am J Ophthalmol Case Rep	2022
35837722	Description of a patient cohort with Hereditary Sensory Neuropathy type 1 without retinal disease Macular Telangiectasia type 2 - implications for retinal screening in HSN1.	J Peripher Nerv Syst	2022
36846105	Macular Telangiectasia Type 2: A Classification System Using MultiModal Imaging MacTel Project Report Number 10.	Ophthalmol Sci	2022
30808615	Right-angled vessels in macular telangiectasia type 2.	Br J Ophthalmol	2021
33654266	Identification of genetic factors influencing metabolic dysregulation and retinal support for MacTel, a retinal disorder.	Commun Biol	2021
33837246	Author Correction: Identification of genetic factors influencing metabolic dysregulation and retinal support for MacTel, a retinal disorder.	Commun Biol	2021
33775659	Fundus Autofluorescence Imaging in Macular Telangiectasia Type 2: MacTel Study Report Number 9.	Am J Ophthalmol	2021
34535475	Effect of ethnicity and other sociodemographic factors on attendance at diabetic eye screening: a 12-month retrospective cohort study.	BMJ Open	2021
33422464	Quantification of Key Retinal Features in Early and Late Age-Related Macular Degeneration Using Deep Learning.	Am J Ophthalmol	2021
33421321	Contextualizing single-arm trials with real-world data: An emulated target trial comparing therapies for neovascular age-related macular degeneration.	Clin Transl Sci	2021
32376611	Diagnostic accuracy of diabetic retinopathy grading by an artificial intelligence-enabled algorithm compared with a human standard for wide-field true-colour confocal scanning and standard digital retinal images.	Br J Ophthalmol	2021
32297923	Effect of Face-Down Positioning vs Support-the-Break Positioning After Macula-Involving Retinal Detachment Repair: The PostRD Randomized Clinical Trial.	JAMA Ophthalmol	2020
31907642	Novel biomarker of sphericity and cylindricity indices in volume-rendering optical coherence tomography angiography in normal and diabetic eyes: a preliminary study.	Graefes Arch Clin Exp Ophthalmol	2020
31800456	DARK ADAPTATION IN MACULAR TELANGIECTASIA TYPE 2.	Retina	2020
31825943	Postretinal Detachment Retinal Displacement: How Best to Detect It?	Ophthalmologica	2020
33230067	WITHDRAWN: Hyper-reflectivity on optical coherence tomography in macular telangiectasia type 2.	Retina	2020
32857270	[Artificial intelligence in ophthalmology : Guidelines for physicians for the critical evaluation of studies].	Ophthalmologe	2020
32818114	Longitudinal Assessment of Remnant Foveal Cone Structure in a Case Series of Early Macular Telangiectasia Type 2.	Transl Vis Sci Technol	2020
32699277	Systemic lipid dysregulation is a risk factor for macular neurodegenerative disease.	Sci Rep	2020
32586743	Macular Telangiectasia Type 2: Visual Acuity, Disease End Stage, and the MacTel Area: MacTel Project Report Number 8.	Ophthalmology	2020
32139499	Comparison of true-colour wide-field confocal scanner imaging with standard fundus photography for diabetic retinopathy screening.	Br J Ophthalmol	2020
29131515	Enhanced resolution and speckle-free three-dimensional printing of macular optical coherence tomography angiography.	Acta Ophthalmol	2019
29858186	Contrast sensitivity and visual acuity under low light conditions in macular telangiectasia type 2.	Br J Ophthalmol	2019
30196286	Stereoscopic Vision in Macular Telangiectasia Type 2.	Ophthalmologica	2019
31415079	Quantification of Retinal and Choriocapillaris Perfusion in Different Stages of Macular Telangiectasia Type 2.	Invest Ophthalmol Vis Sci	2019
31529080	Binocular Inhibition of Reading in Macular Telangiectasia Type 2.	Invest Ophthalmol Vis Sci	2019
31293809	High-Resolution In Vivo Fundus Angiography using a Nonadaptive Optics Imaging System.	Transl Vis Sci Technol	2019
31509666	Serine and Lipid Metabolism in Macular Disease and Peripheral Neuropathy.	N Engl J Med	2019
31419240	Validation of automated artificial intelligence segmentation of optical coherence tomography images.	PLoS One	2019
30839157	Feasibility of support vector machine learning in age-related macular degeneration using small sample yielding sparse optical coherence tomography data.	Acta Ophthalmol	2019
30735236	Estimating Retinal Sensitivity Using Optical Coherence Tomography With Deep-Learning Algorithms in Macular Telangiectasia Type 2.	JAMA Netw Open	2019
30968592	Progression characteristics of ellipsoid zone loss in macular telangiectasia type 2.	Acta Ophthalmol	2019
31022297	Dark-Adapted Two-Color Fundus-Controlled Perimetry in Macular Telangiectasia Type 2.	Invest Ophthalmol Vis Sci	2019
28195982	IDENTIFICATION OF INCREASED BLUE LIGHT REFLECTIVITY IN MACULAR TELANGIECTASIA TYPE 2 USING SCANNING LASER OPHTHALMOSCOPY VERSUS RED-FREE FUNDUS PHOTOGRAPHY.	Retin Cases Brief Rep	2019
28654457	EFFECT OF DARK ADAPTATION AND BLEACHING ON BLUE LIGHT REFLECTANCE IMAGING IN MACULAR TELANGIECTASIA TYPE 2.	Retina	2018
30002949	High-Performance Virtual Reality Volume Rendering of Original Optical Coherence Tomography Point-Cloud Data Enhanced With Real-Time Ray Casting.	Transl Vis Sci Technol	2018
30053477	Macular Pigment Distribution as Prognostic Marker for Disease Progression in Macular Telangiectasia Type 2.	Am J Ophthalmol	2018
30050725	Safety and Feasibility of a Novel Sparse Optical Coherence Tomography Device for Patient-Delivered Retina Home Monitoring.	Transl Vis Sci Technol	2018
28541959	LONGITUDINAL CORRELATION OF ELLIPSOID ZONE LOSS AND FUNCTIONAL LOSS IN MACULAR TELANGIECTASIA TYPE 2.	Retina	2018
28834952	MACULAR TELANGIECTASIA TYPE 2: Quantitative Analysis of a Novel Phenotype and Implications for the Pathobiology of the Disease.	Retina	2018
28505012	CORRELATION OF CLINICAL AND STRUCTURAL PROGRESSION WITH VISUAL ACUITY LOSS IN MACULAR TELANGIECTASIA TYPE 2: MacTel Project Report No. 6-The MacTel Research Group.	Retina	2018
28609329	SCOTOMA CHARACTERISTICS IN MACULAR TELANGIECTASIA TYPE 2: MacTel Project Report No. 7-The MacTel Research Group.	Retina	2018
28654458	ELECTROPHYSIOLOGICAL CHARACTERIZATION OF MACULAR TELANGIECTASIA TYPE 2 AND STRUCTURE-FUNCTION CORRELATION.	Retina	2018
28337251	Pentaerythritol Tetranitrate In Vivo Treatment Improves Oxidative Stress and Vascular Dysfunction by Suppression of Endothelin-1 Signaling in Monocrotaline-Induced Pulmonary Hypertension.	Oxid Med Cell Longev	2017
25904296	In-vivo mapping of drusen by fundus autofluorescence and spectral-domain optical coherence tomography imaging.	Graefes Arch Clin Exp Ophthalmol	2016
26618805	VERY EARLY DISEASE MANIFESTATIONS OF MACULAR TELANGIECTASIA TYPE 2.	Retina	2016
26501828	Treatment for Macular Telangiectasia Type 2.	Dev Ophthalmol	2016
26070062	Progression of Vision Loss in Macular Telangiectasia Type 2.	Invest Ophthalmol Vis Sci	2015

1 - 50 of 62

Giulia Corradetti

Doheny Eye Institute, University of California Los Angeles

Career Start Year 2011

Number of shared co-authors 3

John B Miller

Harvard Medical School

Career Start Year 2011

Number of shared co-authors 0

Amitha Domalpally

University of Wisconsin-Madison School of Medicine and Public Health

Career Start Year 2009

Number of shared co-authors 9

Jay Chhablani

University of Pittsburgh

Career Start Year 2008

Number of shared co-authors 11

Daniela Ferrara

Tufts Medical Center, Tufts University School of Medicine

Career Start Year 2007

Number of shared co-authors 12

Kelvin Yi Chong Teo

Singapore Eye Research Institute

Career Start Year 2007

Number of shared co-authors 4

Shyamanga Borooah

Shiley Eye Institute, University of California

Career Start Year 2007

Number of shared co-authors 2

Chui Ming Gemmy Cheung

Singapore Eye Research Institute

Career Start Year 2002

Number of shared co-authors 11

Eleonora M Lad

Duke University Medical Center

Career Start Year 2002

Number of shared co-authors 13

Nadia K Waheed

Tufts University School of Medicine

Career Start Year 2001

Number of shared co-authors 17

Jayashree Sahni

Novartis Pharma AG

Career Start Year 2001

Number of shared co-authors 8

Catherine A Cukras

Unit on Clinical Investigation of Retinal Disease, National Eye Institute

Career Start Year 2000

Number of shared co-authors 8

Amani A Fawzi

Feinberg School of Medicine, Northwestern University

Career Start Year 2000

Number of shared co-authors 5

Nicolas Leveziel

Universite de Poitiers, INSERM 4 Department of Ophthalmology

Career Start Year 2000

Number of shared co-authors 7

Igor Kozak

Moorfields Eye Hospital Dubai.

Career Start Year 1999

Number of shared co-authors 8

Sobha Sivaprasad

NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital

Career Start Year 1999

Number of shared co-authors 30

Andrew C Browning

Royal Victoria Infirmary

Career Start Year 1999

Number of shared co-authors 9

Fred K Chen

Royal Perth Hospital

Career Start Year 1997

Number of shared co-authors 14

Richard B Rosen

New York Ear and Eye Infirmary of Mount Sinai

Career Start Year 1996

Number of shared co-authors 4

Ursula Schmidt-Erfurth

Medical University of Vienna

Career Start Year 1994

Number of shared co-authors 11

Eric H Souied

University of Paris Est-Creteil

Career Start Year 1994

Number of shared co-authors 18

SriniVas R Sadda

Doheny Eye Institute, University of California Los Angeles

Career Start Year 1993

Number of shared co-authors 24

Allen C Ho

Wills Eye Hospital/Mid Atlantic Retina

Career Start Year 1992

Number of shared co-authors 3

Kenneth Bailey Freund

NYU Grossman School of Medicine

Career Start Year 1991

Number of shared co-authors 16

Giovanni Staurenghi

Eye Clinic, Department of Biomedical and Clinical Science, University of Milan

Career Start Year 1987

Number of shared co-authors 16

David Sarraf

Stein Eye Institute, University of California Los Angeles

Career Start Year 1986

Number of shared co-authors 11

Usha Chakravarthy

Queen's University Belfast

Career Start Year 1985

Number of shared co-authors 27

Philip J Rosenfeld

Bascom Palmer Eye Institute, University of Miami Miller School of Medicine

Career Start Year 1981

Number of shared co-authors 17

Neil M Bressler

Wilmer Eye Institute, Johns Hopkins University School of Medicine

Career Start Year 1979

Number of shared co-authors 8

Maureen G Maguire

Perelman School of Medicine, University of Pennsylvania

Career Start Year 1979

Number of shared co-authors 6

row(s) 1 - 30 of 30

Catherine Egan

Moorfields Eye Hospital NHS Foundation Trust

Co-authored papers 29

Frank G Holz

University of Bonn

Co-authored papers 25

Peter Charbel Issa

Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust

Co-authored papers 22

Adnan Tufail

Moorfields Eye Hospital NHS Foundation Trust

Co-authored papers 14

Marcus Fruttiger

UCL Institute of Ophthalmology

Co-authored papers 13

Mali Okada

Royal Victorian Eye and Ear Hospital

Co-authored papers 11

Peter M Maloca

Institute of Molecular and Clinical Ophthalmology Basel (IOB)

Co-authored papers 10

Konstantinos Balaskas

University of Manchester

Co-authored papers 10

Hendrik P N Scholl

Institute of Molecular and Clinical Ophthalmology Basel

Co-authored papers 8

Tunde Peto

Queen's University Belfast

Co-authored papers 7

Traci E Clemons

The EMMES Corporation

Co-authored papers 7

Martin Friedlander

the Scripps Research Institute

Co-authored papers 6

Emily Y Chew

National Eye Institute, National Institutes of Health

Co-authored papers 6

Irene Leung

Moorfields Eye Hospital

Co-authored papers 5

Abraham Olvera-Barrios

Moorfields Eye Hospital NHS Foundation Trust

Co-authored papers 5

Pascal W Hasler

University Hospital Basel

Co-authored papers 5

Melanie Bahlo

Co-authored papers 4

Roy Schwartz

Moorfields Eye Hospital NHS Foundation Trust

Co-authored papers 3

Aaron Lee

Harvard University, Moorfields Eye Hospital NHS Foundation Trust, St. John's Mercy Hospital, University of British Columbia, University of Washington, Washington University in Saint Louis

Co-authored papers 3

Rando Allikmets

Columbia University Medical Center

Co-authored papers 3

Philipp L M??ller

Moorfields Eye Hospital NHS Foundation Trust

Co-authored papers 3

Lea Scheppke

Lowy Medical Research Institute, California The Scripps Research Institute

Co-authored papers 3

Richard F Spaide

New York University Grossman School of Medicine